The anti‐tumor efficacy of BAFF‐R CAR T therapy in NOD scid gamma mouse (NSG) mouse models using ALL and NHL cell lines have been confirmed35, 47; unfortunately, we experienced challenges in engineering HG3 and CII cell lines to robustly express luciferase. The gene discussed is TNFRSF13C; the disease is non-Hodgkin lymphoma.